{
 "awd_id": "0319444",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Standard Grant",
 "awd_titl_txt": "SBIR Phase I:    Biocompatible Magnetic Drug Delivery Systems that Allow for Greatly Diminished Doses",
 "cfda_num": "47.084",
 "org_code": "15030000",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "Om P. Sahai",
 "awd_eff_date": "2003-07-01",
 "awd_exp_date": "2003-12-31",
 "tot_intn_awd_amt": 99999.0,
 "awd_amount": 99999.0,
 "awd_min_amd_letter_date": "2003-06-03",
 "awd_max_amd_letter_date": "2003-06-03",
 "awd_abstract_narration": "This Small Business Innovation Research (SBIR) Phase I project is to develop noble metal and polymer stabilized magnetic nanoparticles and biodegradable microspheres as nanovehicles for use in magnetically guided drug delivery.  Site-specific release of therapeutic agents results in greatly reduced whole body dosages to minimize toxicity.  Controlled, ultra thin coatings for magnetic nanoparticles would yield biocompatible systems with significantly improved magnetic susceptibility required for effective magnetic guidance through the arterial system.  Analgesics and stable magnetic nanoparticles would be contained in and subsequently released from biodegradable polymeric microspheres.\r\n\r\nThe commercial applications of these highly magnetic nano-vehicles would be as Nuclear Magnetic Resonance (NMR) imaging contrast agents, magnetically guided drug delivery systems, and for cell separation techniques.",
 "awd_arra_amount": 0.0,
 "dir_abbr": "TIP",
 "org_dir_long_name": "Directorate for Technology, Innovation, and Partnerships",
 "div_abbr": "TI",
 "org_div_long_name": "Translational Impacts",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Dr. Jennifer",
   "pi_last_name": "Lalli",
   "pi_mid_init": "",
   "pi_sufx_name": "",
   "pi_full_name": "Dr. Jennifer Lalli",
   "pi_email_addr": "jhlalli@nanosonic.com",
   "nsf_id": "000225114",
   "pi_start_date": "2003-06-03",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "Nanosonic Inc.",
  "inst_street_address": "158 WHEATLAND DR",
  "inst_street_address_2": "",
  "inst_city_name": "PEMBROKE",
  "inst_state_code": "VA",
  "inst_state_name": "Virginia",
  "inst_phone_num": "5406266266",
  "inst_zip_code": "241363645",
  "inst_country_name": "United States",
  "cong_dist_code": "09",
  "st_cong_dist_code": "VA09",
  "org_lgl_bus_name": "NANOSONIC INC.",
  "org_prnt_uei_num": "",
  "org_uei_num": "ZK7ECNMN7MM5"
 },
 "perf_inst": {
  "perf_inst_name": "Nanosonic Inc.",
  "perf_str_addr": "158 WHEATLAND DR",
  "perf_city_name": "PEMBROKE",
  "perf_st_code": "VA",
  "perf_st_name": "Virginia",
  "perf_zip_code": "241363645",
  "perf_ctry_code": "US",
  "perf_cong_dist": "09",
  "perf_st_cong_dist": "VA09",
  "perf_ctry_name": "",
  "perf_ctry_flag": "1"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "537100",
   "pgm_ele_name": "SBIR Phase I"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "9181",
   "pgm_ref_txt": "BIOPROCESSING/BIOMOLECULAR MATERIALS"
  },
  {
   "pgm_ref_code": "BIOT",
   "pgm_ref_txt": "BIOTECHNOLOGY"
  }
 ],
 "app_fund": [
  {
   "app_code": "0103",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "490100",
   "fund_code": "app-0103",
   "fund_name": "",
   "fund_symb_id": ""
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 2003,
   "fund_oblg_amt": 99999.0
  }
 ],
 "por": null
}